Takeda Ventures, Inc., 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN), sold 220,418 shares at $18.05 ($4.0M) on 2021-12-06, disclosed to the SEC on 2021-12-07.
Open-market sale of $4.0M DAWN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.47 | 12,517 | $231K | 5.8% |
| 2 | $18.47 | 12,517 | $231K | 5.8% |
| 3 | $18.05 | 97,692 | $1.8M | 44.2% |
| 4 | $18.05 | 97,692 | $1.8M | 44.2% |
| Total | $18.10 avg | 220,418 | $4.0M | 100% |